Review: taking Metoprolol succinate and Septra ds together


Summary

Drug interactions are reported among people who take Metoprolol succinate and Septra ds together. This review analyzes the effectiveness and drug interactions between Metoprolol succinate and Septra ds. It is created by eHealthMe based on reports of 1,122 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol succinate and Septra ds >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Succinate

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. (latest outcomes from Metoprolol succinate 17,254 users)

Septra Ds

Septra ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. (latest outcomes from Septra ds 1,339 users)

On Jul, 24, 2016

1,122 people who take Metoprolol Succinate, Septra Ds are studied.


Number of reports submitted per year:

Metoprolol succinate and Septra ds drug interactions.

Drug effectiveness over time:

Metoprolol Succinate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 3 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Septra Ds:
  • < 1 month: 33.0% - (2 of 6 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Metoprolol Succinate:
  • female: 44.0% - (4 of 9 people)
  • male: 50.0% - (2 of 4 people)
Septra Ds:
  • female: 37.0% - (3 of 8 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Metoprolol Succinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 33.0% - (2 of 6 people)
Septra Ds:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 66.0% - (4 of 6 people)

Most common drug interactions over time *:

< 1 month:
  • blood creatinine increased
  • international normalised ratio increased
  • abscess
  • exostosis
  • localised infection
  • muscular weakness
  • post procedural haemorrhage
  • skin ulcer
  • thrombocytopenia
  • diverticulitis
1 - 6 months:
  • cytomegalovirus infection
  • gastric ulcer
  • blood creatinine increased
  • diarrhoea
  • renal artery stenosis
  • renal cell carcinoma
  • bronchopneumonia
  • gastritis
  • type 2 diabetes mellitus
  • asthenia
6 - 12 months:
  • fatigue
  • drug rash with eosinophilia and systemic symptoms
  • escherichia infection
  • hepatic failure
  • renal failure acute
  • sepsis
  • vertigo
  • abdominal pain upper
  • blood creatinine increased
  • drug ineffective
1 - 2 years:
  • dizziness
  • supraventricular extrasystoles
  • ventricular extrasystoles
  • abdominal pain upper
  • bronchitis
  • cerebrovascular accident
  • cholecystitis
  • cholelithiasis
  • coronary artery disease
  • cough
2 - 5 years:
  • emotional distress
  • injury
  • myocardial infarction
  • pain
  • abdominal discomfort
  • balance disorder
  • diarrhoea
  • dysarthria
  • dysuria
  • fatigue
5 - 10 years:
  • cerebrovascular accident
  • death
  • fear
  • injury
  • multi-organ failure
  • pain
  • renal failure
  • stress
  • anhedonia
  • anxiety
10+ years:
  • fatigue
  • menstrual periods - heavy, prolonged, or irregular
  • muscle aches
  • nasal dryness
  • postnasal drip
  • productive cough
  • sweating increased
  • uti - chronic or recurrent
not specified:
  • anaemia
  • pain
  • fatigue
  • anxiety
  • dyspnoea
  • dizziness
  • nausea
  • diarrhoea
  • hypertension
  • headache

Most common drug interactions by gender *:

female:
  • anaemia
  • pain
  • anxiety
  • fatigue
  • hypertension
  • headache
  • nausea
  • dizziness
  • urinary tract infection
  • injury
male:
  • diarrhoea
  • dyspnoea
  • fatigue
  • anaemia
  • pain
  • dizziness
  • chest pain
  • cough
  • nausea
  • abdominal pain

Most common drug interactions by age *:

2-9:
  • cardiomyopathy
20-29:
  • blood creatinine increased
  • nausea
  • pyrexia
  • supraventricular tachycardia
  • hydronephrosis
  • vomiting
  • back pain
  • cytomegalovirus infection
  • drug exposure during pregnancy
  • sinusitis
30-39:
  • anxiety
  • blood creatinine increased
  • nausea
  • hypertension
  • diarrhoea
  • abdominal pain upper
  • neuropathy peripheral
  • pain
  • pyrexia
  • renal failure
40-49:
  • pain
  • headache
  • anxiety
  • osteonecrosis of jaw
  • constipation
  • pleural effusion
  • abdominal pain
  • pneumonia
  • chest pain
  • nausea
50-59:
  • fatigue
  • fall
  • anaemia
  • hypertension
  • headache
  • nausea
  • dizziness
  • blood pressure increased
  • chest pain
  • blood triglycerides increased
60+:
  • fatigue
  • anaemia
  • pain
  • dizziness
  • dyspnoea
  • atrial fibrillation
  • diarrhoea
  • bone disorder
  • anxiety
  • injury

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol succinate and Septra ds?

Can you answer these questions?

More questions for: Metoprolol succinate, Septra ds

You may be interested in these reviews

More reviews for: Metoprolol succinate, Septra ds

On eHealthMe, Metoprolol succinate (metoprolol succinate) is often used to treat high blood pressure. Septra ds (sulfamethoxazole; trimethoprim) is often used to treat urinary tract infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.